- Front Matter
1
- 10.1080/1059924x.2024.2446259
The Sixth International Fishing Industry Safety and Health Conference (IFISH 6): Safety, Health, and Wellbeing in a Changing World
- Jan 09, 2025
- Journal of Agromedicine
- Jennifer M Lincoln + 3 more +3
Publications from 2021 to 2026
Showing 10 of 91 papers
The Sixth International Fishing Industry Safety and Health Conference (IFISH 6): Safety, Health, and Wellbeing in a Changing World
Abstract 4147790: Comparison of Clinical Efficacy and Safety of Different Advanced Treatment Strategies for Acute Pulmonary Embolism: A Bayesian Network Meta-analysis
Background: Anticoagulation therapy (ACT) remains the cornerstone of acute pulmonary embolism (PE) management and reduces the mortality risk to <1% in low-risk PE. However, AC is inadequate in intermediate and high-risk acute PE, thus requiring additional therapies. So, there has been a search for better advancement in therapeutic approaches, including catheter-directed thrombolysis (CDT) or thrombectomy, surgical embolectomy (SE), or mechanical thrombectomy (MT). We performed this network meta-analysis to analyze the outcome of different therapeutic approaches for acute intermediate and high-risk PE. Method: We conducted a Bayesian network meta-analysis to synthesize direct and indirect evidence from pertinent studies published until May 2024 using PubMed, Embase, and Scopus databases comparing different therapies for intermediate and high-risk PE patients. This study is registered with PROSPERO, and data analysis was performed using the “BUGSnet” package in R. Result: This analysis included 1,639,413 patients with intermediate or high-risk PE from 72 studies. The probability of CDT being ranked highest was for short-term mortality (catheter-directed intervention: 93), long-term mortality (Ultrasound-assisted Thrombolysis (USAT): 86.17), major bleeding (USAT: 85.58), and intracranial hemorrhage (USAT: 86.06) whereas surgical embolectomy for any and gastro-intestinal bleedings (93.76 and 78.7) respectively. The risk of short-term mortality and intracranial hemorrhage were lower among the patients treated with USAT [(OR: 0.38, CrI: 0.17 to 0.81) and (OR: 0.27, CrI: 0.10 to 0.69)] than those treated with AC only and MT in a random effects model. Conclusion: Based on the findings of this network meta-analysis, compared to other advanced PE management modalities, catheter-based interventions, especially ultrasound-assisted thrombolysis, could potentially reduce short and long-term mortality risk without increasing bleeding risk.
Read moreAbstract 4138475: Comparative Outcomes of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement in Patients with Right Heart Failure: Insights from Nationwide Readmission Database
Background: The annual number of transcatheter aortic valve implantation (TAVI) performed has surpassed that of surgical aortic valve replacement (SAVR) as its use expands to patient populations not included in initial clinical trials. However, in patients with Right Heart Failure (RHF), the outcomes of TAVI and SAVR remain unclear. Methods: We conducted a retrospective cohort study using the Nationwide Readmission Database from 2018 to 2021. Using ICD-10 codes, we identified all adult admissions for TAVI and SAVR with the presence of RHF. The primary outcome was in-hospital mortality. Secondary outcomes included in-hospital complications, 30-day readmission rate, length of stay, and total hospitalization charges. Results: The study included 3,712 adult patients with RHF, of which 1,386 (37.3%) underwent TAVI and 2,326 (62.7%) underwent SAVR. Compared to SAVR patients, TAVI patients were older (63 years vs. 76 years, p<0.01) and had a higher burden of peripheral vascular disease, chronic liver disease, and coagulopathy, while SAVR patients had a higher burden of hypertension, diabetes mellitus, coronary artery disease, left heart failure, chronic lung disease, smoking, malignancy, and anemia. On multivariable analysis, compared to TAVI, SAVR was associated with higher odds of mortality (26.6% vs. 9.3%, p<0.01), mechanical circulatory support use (41.5% vs. 9.22%, p<0.01), respiratory failure (34.2% vs. 10.2%, p<0.01), acute kidney injury (58.1% vs. 37.7%, p<0.01), and need for blood transfusion (31.4% vs. 11.0%, p<0.01). There was no difference in 30-day readmission (13.8% vs. 14.3%, p=0.51) and permanent pacemaker implantation (7.0% vs. 8.7%, p=0.33). SAVR was associated with a longer median hospital stay (14 days vs. 8 days, p<0.01) and higher hospitalization charges ($406,826 vs $265,303, p<0.01). When compared to patients wihout RHF, the presence of RHF predicted higher in-hospital mortality for both TAVI (9.3% vs. 1.2%, p<0.01) as well as SAVR (26.6% vs. 3.7%, p<0.01). Conclusions: From 2018 to 2021, more RHF patients underwent SAVR (62.7%) than TAVI (37.3%), but SAVR was associated with worse short-term outcomes, including higher in-hospital mortality, in-hospital complications, and healthcare resource utilization.
Read moreHealth Care Engagement in Disease Prevention and Management: Factors Influencing Chronic Disease Program Referral Adherence Among Non-Hispanic Black and Hispanic Men With Chronic Conditions.
This study aimed to identify factors associated with being referred to an evidence-based disease prevention and management program by a health care provider and adherence to such referrals by non-Hispanic Black and Hispanic men. Utilizing a cross-sectional design, data were collected via an internet-based questionnaire from a national sample of 1,679 non-Hispanic Black and Hispanic men ages 40 years and older with one or more chronic diseases. A 105-item survey assessed program referral and attendance, chronic conditions and medications, disease symptoms, support, communication during physician visit, health care frustrations, disease self-management efficacy, barriers to self-care, helpfulness of learning from others for self-care, and sociodemographics. Binary logistic regression models were fitted to assess factors associated with referrals to a disease prevention and management program and attendance. Results indicated that approximately 23% of participants were referred to a program, and 19.2% reported attendance. Factors associated with being referred to and attending a program included being younger, having more chronic conditions, taking more medications daily, having higher pain scores, reporting more health care frustrations, and reporting better communication with physicians during visits. Men referred to attend a chronic disease program by a health care provider were 16.86 times more likely to attend a chronic disease program (p < .001). These findings suggest the importance of health care engagement for non-clinical disease prevention and management programs, particularly among non-Hispanic Black and Hispanic men with complex disease profiles.
Read moreManaging Human Resources and Organizational Talent
It's just a body: A community-based participatory exploration of the experiences and health care needs for transgender plural people
TCT-345 Transcatheter Versus Surgical Pulmonary Valve Replacement: A Meta-Regression Analysis
Analyzing the complications of children with obesity: a systematic review of its effective management based on the latest guidelines
The epidemic of children with obesity has quickly become a significant issue for public health worldwide. Positive energy balance owing to calorie intake exceeding caloric expenditure and a genetic propensity for weight growth is the most prevalent cause of obesity. The goal of evaluating children with obesity is to identify the factors that led to their weight increase and any associated health problems. Children's weight control rests mainly on family-based lifestyle treatments, such as food changes and increased physical activity. A study was conducted to understand and evaluate the measures for effectively managing the complications in children with obesity. The study was carried out based on PRISMA guidelines. The systematic literature search was conducted between 2018 to 2023 from databases such as Medline/PubMed and psych info. Considering the inclusion criteria, 44 articles were included in the present review. The result showed that most of the studies included in this review were conducted on adolescents with obesity aged 5-19 years. Much of the research was a randomized cohort study that focused on the interventions for effective weight management in adolescents. Many studies also included parents and pregnant women as their study subjects. The findings of the studies involved in this review suggested the prognostic factors and different treatment programs that can reduce the consequences of obesity developing into adulthood. Since this is one of the first reviews of its kind, the results might prove helpful in making predictions about potential solutions to the issue of obesity and opening the door to more research into treatment strategies for reducing the adverse impacts of obesity on children.
Read moreCOVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
POTS (Postural Orthostatic Tachycardia Syndrome) is a multisystem disorder characterized by the abnormal autonomic response to an upright posture, causing orthostatic intolerance and excessive tachycardia without hypotension. Recent reports suggest that a significant percentage of COVID-19 survivors develop POTS within 6 to 8 months of infection. Prominent symptoms of POTS include fatigue, orthostatic intolerance, tachycardia, and cognitive impairment. The exact mechanisms of post-COVID-19 POTS are unclear. Still, different hypotheses have been given, including autoantibody production against autonomic nerve fibers, direct toxic effects of SARS-CoV-2, or sympathetic nervous system stimulation secondary to infection. Physicians should have a high suspicion of POTS in COVID-19 survival when presented with symptoms of autonomic dysfunction and should conduct diagnostic tests like the Tilt table and others to confirm it. The management of COVID-19-related POTS requires a comprehensive approach. Most patients respond to initial non-pharmacological options, but when the symptoms become more severe and they do not respond to the non-pharmacological approach, pharmacological options are considered. We have limited understanding and knowledge of post-COVID-19 POTS, and further research is warranted to improve our understanding and formulate a better management plan.
Read moreChanges in physical activity outcomes in the Strong Hearts, Healthy Communities (SHHC-2.0) community-based randomized trial
BackgroundPhysical inactivity is a risk factor for numerous adverse health conditions and outcomes, including all-cause mortality. Aging rural women are at particular risk for physical inactivity based on environmental, sociocultural, and psychosocial factors. This study reports on changes in physical activity and associated factors from a multicomponent community-engaged intervention trial.MethodsStrong Hearts, Healthy Communities 2.0 (SHHC-2.0) was a 24-week cluster (community) randomized controlled trial building on the results from the previous trial of SHHC-1.0. Rural women (n = 182) aged 40 and over living in 11 rural communities in upstate New York were recruited. The intervention consisted of twice-weekly experiential classes focused on exercise, nutrition, and civic engagement. Physical activity outcomes included accelerometry and self-report as well as related psychosocial measures at midpoint (12 weeks) and post-intervention (24 weeks). Data were analyzed using multilevel linear regression models with the community as the random effect.ResultsCompared to participants from the control communities, participants in the intervention communities showed a significant increase in objectively measured moderate to vigorous intensity physical activity: at 12 weeks (increase of 8.1 min per day, P < 0.001) and at 24 weeks (increase of 6.4 min per day; P = 0.011). Self-reported total MET minutes per week also increased: at 12 weeks (increase of 725.8, P = 0.003) and 24 weeks (increase of 955.9, P = 0.002). Several of the psychosocial variables also showed significant positive changes.ConclusionsThe SHHC-2.0 intervention successfully increased physical activity level and related outcome measures. Modifications made based upon in-depth process evaluation from SHHC-1.0 appear to have been effective in increasing physical activity in this at-risk population.Trial registrationClinicaltrials.gov: NCT03059472. Registered 23 February 2017.
Read more